Wounds - Pipeline Review, H2 2017

Global Markets Direct’s, ‘Wounds - Pipeline Review, H2 2017’, provides an overview of the Wounds pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Wounds, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Wounds and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Wounds

The report reviews pipeline therapeutics for Wounds by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Wounds therapeutics and enlists all their major and minor projects

The report assesses Wounds therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Wounds

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Wounds

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Wounds pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Advanced Inhalation Therapies (AIT) Ltd

AlgiPharma AS

Alliance Pharma Plc

AmpliPhi Biosciences Corp

AndroScience Corp

Aridis Pharmaceuticals LLC

Beech Tree Labs Inc

Bioblue Technologies Inc ...

Advanced Inhalation Therapies (AIT) Ltd

AlgiPharma AS

Alliance Pharma Plc

AmpliPhi Biosciences Corp

AndroScience Corp

Aridis Pharmaceuticals LLC

Beech Tree Labs Inc

Bioblue Technologies Inc

Biotec Pharmacon ASA

Cellphire Inc

Chiesi Farmaceutici SpA

CorMedix Inc

CytoTools AG

Dermala Inc

Destiny Pharma Ltd

Escape Therapeutics Inc

Exicure Inc

Exogenus Therapeutics SA

FibroGen Inc

Gene Signal International SA

GlaxoSmithKline Plc

IC-MedTech Inc

Living Cell Technologies Ltd

Madam Therapeutics BV

MediWound Ltd

Miragen Therapeutics Inc

NatureWise Biotech & Medicals Corp

Nippon Chemiphar Co Ltd

Novan Inc

Octapharma AG

Omeros Corp

Osiris Therapeutics Inc

Pacific Northwest Biotechnology LLC

ProMetic Life Sciences Inc

SomaGenics Inc

Stratatech Corp

Synedgen Inc

Thesan Pharmaceuticals Inc

Topadur Pharma AG

Traverse Biosciences Inc

Tumorend LLC

Vascular BioSciences

viDA Therapeutics Inc

Table of Contents

Table of Contents

Table of Contents 2

Introduction 5

Wounds – Overview 6

Wounds – Therapeutics Development 7

Wounds – Therapeutics Assessment 21

Wounds – Companies Involved in Therapeutics ...

Table of Contents

Table of Contents 2

Introduction 5

Wounds – Overview 6

Wounds – Therapeutics Development 7

Wounds – Therapeutics Assessment 21

Wounds – Companies Involved in Therapeutics Development 31

Wounds – Drug Profiles 49

Wounds – Dormant Projects 179

Wounds – Discontinued Products 185

Wounds – Product Development Milestones 186

Appendix 198

List of Tables

List of Tables

Number of Products under Development for Wounds, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under ...

List of Tables

Number of Products under Development for Wounds, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Products under Development by Companies, H2 2017

Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Products under Development by Universities/Institutes, H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Wounds – Pipeline by Advanced Inhalation Therapies (AIT) Ltd, H2 2017

Wounds – Pipeline by AlgiPharma AS, H2 2017

Wounds – Pipeline by Alliance Pharma Plc, H2 2017

Wounds – Pipeline by AmpliPhi Biosciences Corp, H2 2017

Wounds – Pipeline by AndroScience Corp, H2 2017

Wounds – Pipeline by Aridis Pharmaceuticals LLC, H2 2017

Wounds – Pipeline by Beech Tree Labs Inc, H2 2017

Wounds – Pipeline by Bioblue Technologies Inc, H2 2017

Wounds – Pipeline by Biotec Pharmacon ASA, H2 2017

Wounds – Pipeline by Cellphire Inc, H2 2017

Wounds – Pipeline by Chiesi Farmaceutici SpA, H2 2017

Wounds – Pipeline by CorMedix Inc, H2 2017

Wounds – Pipeline by CytoTools AG, H2 2017

Wounds – Pipeline by Dermala Inc, H2 2017

Wounds – Pipeline by Destiny Pharma Ltd, H2 2017

Wounds – Pipeline by Escape Therapeutics Inc, H2 2017

Wounds – Pipeline by Exicure Inc, H2 2017

Wounds – Pipeline by Exogenus Therapeutics SA, H2 2017

Wounds – Pipeline by FibroGen Inc, H2 2017

Wounds – Pipeline by Gene Signal International SA, H2 2017

Wounds – Pipeline by GlaxoSmithKline Plc, H2 2017

Wounds – Pipeline by IC-MedTech Inc, H2 2017

Wounds – Pipeline by Living Cell Technologies Ltd, H2 2017

Wounds – Pipeline by Madam Therapeutics BV, H2 2017

Wounds – Pipeline by MediWound Ltd, H2 2017

Wounds – Pipeline by Miragen Therapeutics Inc, H2 2017

Wounds – Pipeline by NatureWise Biotech & Medicals Corp, H2 2017

Wounds – Pipeline by Nippon Chemiphar Co Ltd, H2 2017

Wounds – Pipeline by Novan Inc, H2 2017

Wounds – Pipeline by Octapharma AG, H2 2017

Wounds – Pipeline by Omeros Corp, H2 2017

Wounds – Pipeline by Osiris Therapeutics Inc, H2 2017

Wounds – Pipeline by Pacific Northwest Biotechnology LLC, H2 2017

Wounds – Pipeline by ProMetic Life Sciences Inc, H2 2017

Wounds – Pipeline by SomaGenics Inc, H2 2017

Wounds – Pipeline by Stratatech Corp, H2 2017

Wounds – Pipeline by Synedgen Inc, H2 2017

Wounds – Pipeline by Thesan Pharmaceuticals Inc, H2 2017

Wounds – Pipeline by Topadur Pharma AG, H2 2017

Wounds – Pipeline by Traverse Biosciences Inc, H2 2017

Wounds – Pipeline by Tumorend LLC, H2 2017

Wounds – Pipeline by Vascular BioSciences, H2 2017

Wounds – Pipeline by viDA Therapeutics Inc, H2 2017

Wounds – Dormant Projects, H2 2017

Wounds – Dormant Projects, H2 2017 (Contd..1), H2 2017

Wounds – Dormant Projects, H2 2017 (Contd..2), H2 2017

Wounds – Dormant Projects, H2 2017 (Contd..3), H2 2017

Wounds – Dormant Projects, H2 2017 (Contd..4), H2 2017

Wounds – Dormant Projects, H2 2017 (Contd..5), H2 2017

Wounds – Discontinued Products, H2 2017

List of Figures

List of Figures

Number of Products under Development for Wounds, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under ...

List of Figures

Number of Products under Development for Wounds, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Routes of Administration, H2 2017

Number of Products by Stage and Routes of Administration, H2 2017

Number of Products by Top 10 Molecule Types, H2 2017

Number of Products by Stage and Top 10 Molecule Types, H2 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports